Plant Summary
Plant Information
TCMBank_ID: | TCMBANKHE004022 |
ID: | TCMBANKHE004022 |
植物拉丁名: |
|
功能与主治: | To tonify the lung and the kidney, arrest bleeding, and dispel phlegm./Impotence and emission, neurasthenia, backache, aching in lumbus and knees, enduring cough and vacuity asthma, taxation damage hemoptysis. |
药用植物名: | 冬虫夏草 |
药用部位: | a drug consisting of dried fungal stroma growing on larva of a caterpillar |
药味: | Mild; Sweet |
经络: | Lung; Kidney |
临床特征: | 1. Relaxing the smooth muscles of bronchus.2. Increasing the anoxia tolerance in mice3. Sedativ, anti-inflammatory. |
治疗类型: | 补阳药 |
TCM_ID_id: | 6269 |
SymMap_id: | 108 |
TCMSP_id: | 223 |
植物对应的化合物
| 化合物ID | 化合物名 | 别名 | 分子式 | 分子质量 | Smiles |
|---|
| TCMBANKIN000071 | cordycepin | NSC108075; NSC-108075; NSC107179; AC1L6ILJ; CTK8A3229; 2-(6-amino-9h-purin-9-yl)-4-(hydroxymethyl)tetrahydrofuran-3-ol; NSC-107179; 2-(6-aminopurin-9-yl)-4-(hydroxymethyl)oxolan-3-ol | C10H13N5O3 | 251.24 | C1C(OC(C1O)N2C=NC3=C(N=CN=C32)N)CO |
| TCMBANKIN000254 | lipodeoxyaconitine | ||||
| TCMBANKIN000548 | Delbruline | delbruline | C26H41NO7 | 479.61 | CCN1CC2(CCC(C34C2C(C5(C31)C6(CC(C7CC4C6C7O)OC)OCO5)OC)OC)COC |
| TCMBANKIN000898 | Uralene | 5,6,3',4'-Tetrahydroxy-3-methoxy-6'-isoprenylflavone; 2-[4,5-dihydroxy-2-(3-methylbut-2-enyl)phenyl]-5,6-dihydroxy-3-methoxy-4-chromenone; 2-(4,5-Dihydroxy-2-(3-methylbut-2-en-1-yl)phenyl)-5,6-dihydroxy-3-methoxy-4H-chromen-4-one; SCHEMBL3977970; LMPK12111615; 4',5,5',6-tetrahydroxy-3-methoxy-2'-prenylflavone; AC1Q6E0V; AKOS030553602; uralene; 4H-1-Benzopyran-4-one, 2-(4,5-dihydroxy-2-(3-methyl-2-butenyl)phenyl)-5,6-dihydroxy-3-methoxy-; 2-[4,5-dihydroxy-2-(3-methylbut-2-enyl)phenyl]-5,6-dihydroxy-3-methoxy-chromen-4-one; AC1L4UEU; 2-[4,5-dihydroxy-2-(3-methylbut-2-enyl)phenyl]-5,6-dihydroxy-3-methoxy-chromone; 150853-99-9; 2-[4,5-Dihydroxy-2-(3-methyl-2-butenyl)phenyl]-5,6-dihydroxy-3-methoxy-4H-1-benzopyran-4-one; AK583653; 2-[4,5-dihydroxy-2-(3-methylbut-2-enyl)phenyl]-5,6-dihydroxy-3-methoxychromen-4-one | C21H20O7 | 384.38 | CC(=CCC1=CC(=C(C=C1C2=C(C(=O)C3=C(O2)C=CC(=C3O)O)OC)O)O)C |
| TCMBANKIN001590 | coryneine chloride | C[N+](C)(C)CCC1=CC(=C(C=C1)O)O.[I-] | |||
| TCMBANKIN001612 | songrine | ||||
| TCMBANKIN002879 | arachidonic acid | (5Z,8Z,11Z,14Z)-5,8,11,14-icosatetraenoic acid; cis-5,8,11,14-Eicosatetraenoic acid; 3435-81-2; 5Z,8Z,11Z,14Z-icosatetraenoic acid; cis,cis,cis,cis-5,8,11,14-Eicosatetraenoic acid; C00219; ACD; Arachidonsaeure; arachidonicacid; DTXSID40473870; (5Z,8Z,11Z,14Z)-Icosatetraenoic acid; ST069383; 93444-49-6; (14C)Arachidonic acid; NCGC00094608-04; 5,8,11,14-Eicosatetraenoic acid, labeled with carbon-14, (all-Z)-; A3555_SIGMA; 5Z,8Z,11Z,14Z-eicosatetraenoic acid; all-cis-5,8,11,14-eicosatetraenoic acid; IDI1_034009; ARACHIDONIC ACID, [1-14C]-; BSPBio_001539; NCGC00094608-02; NCGC00094608-03; AIDS045704; CHEBI:15843; NCGC00094608-01; (5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoic acid; cis-Delta(5,8,11,14)-eicosatetraenoic acid; A3925_SIGMA; ACM3435812; Spectrum5_001910; Arachidonic acid-carboxy-14C; A9673_SIGMA; LMFA01030001; AIDS-045704; 10931_FLUKA; <i>cis,cis,cis,cis</i>-5,8,11,14-Eicosatetraenoic Acid | C20H32O2 | 304.5 g/mol | CCCCCC=CCC=CCC=CCC=CCCCC(=O)O |
| TCMBANKIN002907 | guanosine | Guanosine, hydrate; s3068; CTK0F0492; Guanosine hydrate (1:1); 2-amino-9-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-1,9-dihyd; YCHNAJLCEKPFHB-GWTDSMLYSA-N; Guanosine, hydrate (1:1); Z-4761; SCHEMBL555106; AK645793; 1143525-19-2; MolPort-003-935-435; guanosine-hydrate; AK607682; 2-Amino-9-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-1H-purin-6(9H)-one hydrate(1:x); 2-amino-9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6,9-dihydro-1H-purin-6-one hydrate; 2451AH; 294B1373-E8C3-442D-8240-D7EA2650B160; AKOS030573276; 141433-61-6; ro-6H-purin-6-one hydrate; 2-amino-9-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-1,9-dihydro-6H-purin-6-one hydrate; Guanosine Hydrate; B3678 | C10H13N5O5 | 283.24 | C1=NC2=C(N1C3C(C(C(O3)CO)O)O)N=C(NC2=O)N |
| TCMBANKIN003053 | karakoline | Karakoline; NCGC00094019-01 | C22H35NO4 | 377.52 | CCN1CC2(CCC(C34C2CC(C31)C5(CC(C6CC4C5C6O)OC)O)O)C |
| TCMBANKIN003765 | Vilmorrianine C | vilmorrianine c | C35H49NO9 | 627.76 | CCN1CC2(CCC(C34C2C(C(C31)C5(CC(C6CC4C5C6OC(=O)C7=CC=C(C=C7)OC)OC)OC(=O)C)OC)OC)COC |
| TCMBANKIN004858 | talatizamine | NSC624752; talatisamine; NSC-624752; Talatizamine | C24H39NO5 | 421.57 | CCN1CC2(CCC(C34C2CC(C31)C5(CC(C6CC4C5C6O)OC)O)OC)COC |
| TCMBANKIN004978 | Galactomannan | (2R,3S,4R,5S,6R)-5-[(2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-methylol-tetrahydropyran-2-yl]oxy-6-[[(2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-methylol-tetrahydropyran-2-yl]oxymethyl]tetrahydropyran-2,3,4-triol; (2R,3S,4R,5S,6R)-5-[(2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-[[(2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxane-2,3,4-triol; galactomannan; (2R,3S,4R,5S,6R)-5-[(2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-6-[[(2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxymethyl]tetrahydropyran-2,3,4-triol; Galactomannoglycan; (2R,3S,4R,5S,6R)-5-[[(2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)-2-tetrahydropyranyl]oxy]-6-[[(2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)-2-tetrahydropyranyl]oxymethyl]tetrahydropyran-2,3,4-triol; C00883 | C18H32O16 | 504.4 g/mol | C(C1C(C(C(C(O1)OCC2C(C(C(C(O2)O)O)O)OC3C(C(C(C(O3)CO)O)O)O)O)O)O)O |
| TCMBANKIN005238 | carnosifloside i | DTXSID50474616; CHEBI:3425; Carnosifloside I; 109985-90-2; C08790; (3S,8S,9R,10R,13R,14S,17R)-17-[(E,1R)-1,5-dimethyl-6-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxymethyl]tetrahydropyran-2-yl]oxy-hex-4-enyl]-3-hydroxy-4,4,9,13,14-pentamethyl-1,2,3,7,8,10,12,15,16,17-decahydrocyclopenta[a]phenanthren-11-one | C42H68O13 | 781 g/mol | CC(CCC=C(C)COC1C(C(C(C(O1)COC2C(C(C(C(O2)CO)O)O)O)O)O)O)C3CCC4(C3(CC(=O)C5(C4CC=C6C5CCC(C6(C)C)O)C)C)C |
| TCMBANKIN005529 | aconine | MFCD09039102; Ambap20562-03-2; alpha-Chaconine; CHEMBL2288884; ZINC245190581; alpha-Chaconine with HPLC; aconine ; (3b)-Solanid-5-en-3-yl O-6-deoxy-a-L-mannopyranosyl-(1-2)-O-(6-deoxy-a-L-mannopyranosyl-(1-4))-b-D-glucopyranoside; a-Chaconine; AC-20170; b-D-Glucopyranoside, (3b)-solanid-5-en-3-yl O-6-deoxy-a-L-mannopyranosyl-(1?2)-O-[6-deoxy-a-L-mannopyranosyl-(1?4)]-; BC216164; AKOS015965211; 20562-03-2 | C25H41NO9 | 499.6 g/mol | CCN1CC2(C(CC(C34C2C(C(C31)C5(C6C4CC(C6O)(C(C5O)OC)O)O)OC)OC)O)COC |
| TCMBANKIN006051 | Delsoline | delsoline | C25H41NO7 | 467.6 | CCN1CC2(CCC(C34C2C(C(C31)(C5(CC(C6CC4C5C6OC)OC)O)O)OC)O)COC |
| TCMBANKIN006144 | Demethyldelavaine B | demethyldelavaine b | 700.91 | CCN1CC2(CCC(C34C2C(C(C31)(C5(CC(C6CC4C5C6OC)OC)O)O)OC)OC)COC(=O)C7=CC=CC=C7NC(=O)CC(C)C(=O)O | |
| TCMBANKIN006155 | Cordylagenin | cordylagenin | 432.71 | ||
| TCMBANKIN007431 | Linoleyl acetate | octadeca-9,12-dien-1-yl acetate; acetic acid [(9E,12E)-octadeca-9,12-dienyl] ester; [(9E,12E)-octadeca-9,12-dienyl] ethanoate; 5999-95-1; FT-0635935; linoleyl acetate; [(9E,12E)-octadeca-9,12-dienyl] acetate | C20H36O2 | 308.5 | CCCCCC=CCC=CCCCCCCCCOC(=O)C |
| TCMBANKIN008206 | delsemine a | C37H53N3O10 | 699.8 g/mol | CCN1CC2(CCC(C34C2C(C(C31)(C5(CC(C6CC4C5C6OC)OC)O)O)OC)OC)COC(=O)C7=CC=CC=C7NC(=O)C(C)CC(=O)N | |
| TCMBANKIN008480 | lipmesaconitine | ||||
| TCMBANKIN009469 | coryneine | AC1Q7ACS; AK608315; 3,4-Dihydroxyphenethyltrimethylammonium; Quaternary dopamine; SCHEMBL4824806; Dopamine methiodide; 7224-66-0; 52336-53-5 (iodide); CHEMBL1179320; CHEBI:81125; 2-(3,4-dihydroxyphenyl)-n,n,n-trimethylethanaminium; AKOS030573589; DTXSID30222576; ZINC1675113; Coryneine; AC1L4WWC; 2-(3,4-dihydroxyphenyl)ethyl-trimethylazanium; C17486 | C11H18NO2+ | 196.27 g/mol | C[N+](C)(C)CCC1=CC(=C(C=C1)O)O |
| TCMBANKIN010602 | diacetylacoritine | CCN1CC2(C(CC(C34C2C(C(C31)C5(C6C4CC(C6OC(=O)C7=CC=CC=C7)(C(C5O)OC)OC(=O)C)O)OC)OC)OC(=O)C)COC | |||
| TCMBANKIN014035 | dl-demetylcolarine | ||||
| TCMBANKIN014507 | 8-deoxy-14-dehydro-aconosine | C22H33NO3 | CCN1CC2CCC(C34C2CC(C31)C5CC(C6CC4C5C6=O)OC)OC | ||
| TCMBANKIN014658 | delavaconitine | Delavaconitine | C29H39NO6 | 497.62 | CCN1CC2CCC(C34C2CC(C31)C5(CC(C6(CC4C5C6OC(=O)C7=CC=CC=C7)O)OC)O)OC |
| TCMBANKIN016397 | Delbrusine | delbrusine | 493.71 | CCN1CC2(CCC(C34C2C(C5(C31)C6(CC(C7CC4C6C7OC)OC)OCO5)OC)OC)COC | |
| TCMBANKIN016528 | Demethyldelavaine A | demethyldelavaine a | 700.91 | CCN1CC2(CCC(C34C2C(C(C31)(C5(CC(C6CC4C5C6OC)OC)O)O)OC)OC)COC(=O)C7=CC=CC=C7NC(=O)C(C)CC(=O)O | |
| TCMBANKIN016581 | neokadsuranic acid C | neokadsuranicacid c; neokadsuranic acid c; AC1NSZ1V; (Z)-6-[(11bS)-4,4,6b,11b-tetramethyl-10-methylidene-3-oxo-1,2,4a,5,6,7,8,9,10a,11-decahydrobenzo[a]fluoren-9-yl]-2-methylhept-2-enoic acid | C30H46O4 | 470.68 | CC(CCC=C(C)C(=O)O)C1CCC2(C(C1(C)O)CC3=C2CCC4C3(CCC(=O)C4(C)C)C)C |
| TCMBANKIN016602 | 3,6-digalloyl glucose | 3,6-Digalloylglucose; AC1O4QKO; 3,6-digalloylglucose; [(2R,3R,4R,5R,6S)-3,5,6-trihydroxy-4-(3,4,5-trihydroxybenzoyl)oxyoxan-2-yl]methyl 3,4,5-trihydroxybenzoate; 3, 6-digalloylglucose | C20H20O14 | 484.36 | C1=C(C=C(C(=C1O)O)O)C(=O)C(C(C(C(C(C=O)O)(C(=O)C2=CC(=C(C(=C2)O)O)O)O)O)O)O |
| TCMBANKIN016722 | triacetylaconine | ||||
| TCMBANKIN017423 | 2, 7-dihydoxy-2, 4-dimethoxy-9, 10-dihydrophenanthrene | C16H16O3 | COC1=CC(=C2C(=C1)CCC3=C2C=CC(=C3)O)OC | ||
| TCMBANKIN017993 | vitamin c | D01CWN; Cell C; Ronotec 100; P 1110; Suncoat VC 40; D-threo-hex-2-enoic acid gamma-lactone; Citrovit; 2-o-(beta-d-glucopyranosyl)-ascorbic acid_qt; Juvamine; SCHEMBL13468284; Vasc; CHEBI:51384; D-Lyxoascorbic acid; CHEMBL1253320; AK481251; Chewcee; D-xyloascorbic acid; C8DQ5M1Y1E; MLS001066386; AK322241; Ascorbic acid, D-; AC1LD8K5; E 300; Scorbu C; 10504-35-5; Ascorbicacid; l(+)-ascorbic acid; ZINC100006137; L-ascorbate (vitamin C); (5S)-5-[(1R)-1,2-dihydroxyethyl]-3,4-dihydroxyfuran-2(5H)-one; (+)-Ascorbic acid; UNII-C8DQ5M1Y1E; Ascorbinsaure; Ceklin; VC 97; (2S)-2-[(1R)-1,2-bis(oxidanyl)ethyl]-4,5-bis(oxidanyl)furan-3-one; Vicin; L-ascorbate acid; L-ascorbic acid; L-dehydroascorbic acid; ascorbate; D-threo-hex-2-enono-1,4-lactone; Kangbingfeng; D-Ascorbic acid; Viscorin 100M; ZINC100028197; (2S)-2-[(1R)-1,2-dihydroxyethyl]-4,5-dihydroxy-3-furanone; L-Ascorbic acid (8CI,9CI); Proscorbin Redoxon Ribena Ronotec 100; Hex-2-enonic acid gamma-lactone, L-threo; (5S)-5-[(1R)-1,2-dihydroxyethyl]-3,4-dihydroxy-2,5-dihydrofuran-2-one; Ascorbic acid; DL-Ascorbic acid; AKOS000278050; Cebion, gamma-lactone; F91F7DA3-A3D5-4FB4-A6E7-C497C48D192A; GTPL4651; SMR000471843; Xyloascorbic acid, L-; Rontex 100; Rovimix C; (2S)-2-[(1R)-1,2-dihydroxyethyl]-4,5-dihydroxyfuran-3-one; A828310 | C6H8O6 | 176.12 | C(C(C1C(=C(C(=O)O1)O)O)O)O |
| TCMBANKIN018625 | delgrandine | C41H43NO12 | 741.8 g/mol | CC(=O)OC1C2C(C3C4C56C1C3(CC2=C)C(C(C5C(C(C(C6OC(=O)C)OC(=O)C7=CC=CC=C7)OC(=O)C)(C)C=O)N4C)O)OC(=O)C8=CC=CC=C8 | |
| TCMBANKIN019801 | benzoylhypaconine | C31H43NO9 | 573.67 | CN1CC2(CCC(C34C2C(C(C31)C5(C6C4CC(C6OC(=O)C7=CC=CC=C7)(C(C5O)OC)O)O)OC)OC)COC | |
| TCMBANKIN019831 | Delcorine | delcorine; NCGC00017000-01; Prestwick-09C05 | C26H41NO7 | 479.61 | CCN1CC2(CCC(C34C2C(C5(C31)C6(CC(C7CC4C6C7OC)OC)OCO5)O)OC)COC |
| TCMBANKIN019857 | bullatine c | 14-acetylneoline | C26H41NO7 | 479.6 g/mol | CCN1CC2(CCC(C34C2C(C(C31)C5(CC(C6CC4C5C6OC(=O)C)OC)O)OC)O)COC |
| TCMBANKIN020661 | higeamine | ||||
| TCMBANKIN020973 | (2R,3R,4S)-2-(6-aminopurin-9-yl)-4-(hydroxymethyl)oxolan-3-ol | (2R,3R,4S)-2-(6-amino-9-purinyl)-4-(hydroxymethyl)-3-tetrahydrofuranol; (2R,3R,4S)-2-(6-aminopurin-9-yl)-4-methylol-tetrahydrofuran-3-ol; (2R,3R,4S)-2-(6-aminopurin-9-yl)-4-(hydroxymethyl)tetrahydrofuran-3-ol | C10H13N5O3 | 251.24 | |
| TCMBANKIN020979 | dictysine | C21H33NO3 | 347.5 g/mol | CC12CCCC34C1CC(C3N(C2)C)C56C4CC(CC5)C(C6O)(CO)O | |
| TCMBANKIN021134 | vitamin b15 | C20H40N2O8 | 436.5 g/mol | CC(C)N(C(C)C)C(C(=O)OCC(C(C(C(C(=O)O)O)O)O)O)N(C(C)C)C(C)C | |
| TCMBANKIN022994 | aconitan | CCN1CC2(CCC(C34C2C(C(C31)(C5(CC(C6CC4C5C6=O)OC)O)O)OC)OC)COC | |||
| TCMBANKIN023050 | TRE | (2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-tetrahydropyran-3,4,5-triol; EINECS 202-739-6; Treha; (2R,3S,4S,5R,6R)-2-methylol-6-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-methylol-tetrahydropyran-2-yl]oxy-tetrahydropyran-3,4,5-triol; D-Trehalose; ZINC04095531; Trehalose (8CI); alpha-trehalose; Trehaose; alpha,alpha'-Trehalose; ST5409604; GLC-(1-1)GLC; C01083; alpha,alpha'-D-Trehalose; (2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)-2-tetrahydropyranyl]oxy]tetrahydropyran-3,4,5-triol; SMP1_000299; alpha-D-Glucopyranoside, a-D-glucopyranosyl (9CI); CHEBI:16551; (2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-oxane-3,4,5-triol; 229966-89-6; (2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxane-3,4,5-triol; NSC 2093; alpha-D-Glucopyranoside, alpha-D-glucopyranosyl; D(+)Trehalose; alpha-D-glucopyranosyl alpha-D-glucopyranoside; alpha-D-Glcp-(1<->1)-alpha-D-Glcp; alpha-D-Trehalose | C12H22O11 | 342.3 | C(C1C(C(C(C(O1)OC2C(C(C(C(O2)CO)O)O)O)O)O)O)O.O.O |
| TCMBANKIN023614 | Neojiangyouaconitine | neojiangyouaconitine | C33H47NO9 | 601.73 | CCN1CC2(CCC(C34C2C(C(C31)C5(C6C4CC(C6OC(=O)C7=CC=CC=C7)(C(C5O)OC)O)OC)OC)OC)COC |
| TCMBANKIN023655 | delphatine | C26H43NO7 | 481.6 g/mol | CCN1CC2(CCC(C34C2C(C(C31)(C5(CC(C6CC4C5C6OC)OC)O)O)OC)OC)COC | |
| TCMBANKIN024257 | Karanjin | TNP00046; karanjin; 7-Methoxy-8-phenylfurano[2,3-h]chromen-6-one; NCGC00017182-01; FLAVONE (BOHLMAN); 4H-Furo(2,3-h)-1-benzopyran-4-one, 3-methoxy-2-phenyl- (8CI)(9CI); AIDS-046608; 3-methoxy-2-phenylthieno[2,3-h]chromen-4-one; AC1NRWWN; 521-88-0; ZINC00039119; 4H-Furo[2,3-h]-1-benzopyran-4-one, 3-methoxy-2-phenyl-; 3-methoxy-2-phenylpyrano[2,3-e][1]benzoxol-4-one; 3-methoxy-2-phenyl-pyrano[2,3-e]benzofuran-4-one; NSC335755; NCGC00142418-01; 4H-Thieno[2,3-h]-1-benzopyran-4-one, 3-methoxy-2-phenyl-; AIDS046608; MEGxp0_001687; NSC 335755; 3-methoxy-2-phenyl-4-pyrano[2,3-e]benzofuranone; ST055657; EINECS 208-319-9; 3-Methoxy-2-phenyl-4H-furo(2,3-h)(1)benzopyran-4-one; 3-methoxy-2-phenyl-pyrano[2,3-e][1]benzoxol-4-one; 3-methoxy-2-phenyl-thieno[2,3-h]chromen-4-one | C18H12O4 | 292.29 | COC1=C(OC2=C(C1=O)C=CC3=C2C=CO3)C4=CC=CC=C4 |
| TCMBANKIN025590 | deoxyaconitine | Deoxyaconitine; CHEMBL400316 | C34H47NO10 | 629.74 | CCN1CC2(CCC(C34C2C(C(C31)C5(C6C4CC(C6OC(=O)C7=CC=CC=C7)(C(C5O)OC)O)OC(=O)C)OC)OC)COC |
| TCMBANKIN025650 | delphin | Delphin; SCHEMBL318115; LMPK12010283; DELPHIN | C27H31O17+ | 627.5 g/mol | C1=C(C=C(C(=C1O)O)O)C2=C(C=C3C(=CC(=CC3=[O+]2)O)OC4C(C(C(C(O4)CO)O)O)O)OC5C(C(C(C(O5)CO)O)O)O |
| TCMBANKIN025687 | Thiamine | (Riboflavin); thiamine; thiamine chloride; vitamin b1 | C12H18Cl2N4OS | 337.3 g/mol | [H+].CC1=C(SC=[N+]1CC2=CN=C(N=C2N)C)CCO.[Cl-].[Cl-] |
| TCMBANKIN025834 | karacoline | Karakoline; 39089-30-0; Karacoline; 20-ethyl-16beta-methoxy-4-methylaconitane-1alpha,8,14alpha-triol; Carmicheline; C08693; STOCK1N-08515; Carmichaeline; CHEBI:6113; Aconitane-1,8,14-triol, 20-ethyl-16-methoxy-4-methyl-, (1-alpha,14-alpha,16-beta)- | C22H35NO4 | 377.5 g/mol | CCN1CC2(CCC(C34C2CC(C31)C5(CC(C6CC4C5C6O)OC)O)O)C |
| TCMBANKIN026143 | mesaconine | C24H39NO9 | 485.6 g/mol | CN1CC2(C(CC(C34C2C(C(C31)C5(C6C4CC(C6O)(C(C5O)OC)O)O)OC)OC)O)COC | |
| TCMBANKIN027096 | delamide | methyl 2-[(4-amino-2-methyl-4-oxobutanoyl)amino]benzoate; AC1NSUBW; AKOS029587771 | C13H16N2O4 | CC(CC(=O)N)C(=O)NC1=CC=CC=C1C(=O)OC | |
| TCMBANKIN027193 | lipaconitine | ||||
| TCMBANKIN028272 | 5,6-epoxy-3-hydroxy- ergosterol | ||||
| TCMBANKIN028454 | 3-acetylaltholactone | C15H14O5 | 274.27 g/mol | CC(=O)OC1C2C(C=CC(=O)O2)OC1C3=CC=CC=C3 | |
| TCMBANKIN028735 | vitamin b12 | C63H88CoN14O14P | 1355.4 g/mol | CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)([O-])OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=C(C7=NC(=CC8=NC(=C(C4=N5)C)C(C8(C)C)CCC(=O)N)C(C7(C)CC(=O)N)CCC(=O)N)C)[N-]6)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+3] | |
| TCMBANKIN028846 | hypaconine | C24H39NO8 | 469.6 g/mol | CN1CC2(CCC(C34C2C(C(C31)C5(C6C4CC(C6O)(C(C5O)OC)O)O)OC)OC)COC | |
| TCMBANKIN030683 | talatisamine | C24H39NO5 | 421.57 | CCN1CC2(CCC(C34C2CC(C31)C5(CC(C6CC4C5C6O)OC)O)OC)COC | |
| TCMBANKIN032162 | ergotamine | C33H35N5O5 | 581.7 g/mol | CC1(C(=O)N2C(C(=O)N3CCCC3C2(O1)O)CC4=CC=CC=C4)NC(=O)C5CN(C6CC7=CNC8=CC=CC(=C78)C6=C5)C | |
| TCMBANKIN032730 | carmichaeline | Karakoline; 39089-30-0; Karacoline; 20-ethyl-16beta-methoxy-4-methylaconitane-1alpha,8,14alpha-triol; Carmicheline; C08693; STOCK1N-08515; Carmichaeline; CHEBI:6113; Aconitane-1,8,14-triol, 20-ethyl-16-methoxy-4-methyl-, (1-alpha,14-alpha,16-beta)- | C22H35NO4 | 377.5 g/mol | CCN1CC2(CCC(C34C2CC(C31)C5(CC(C6CC4C5C6O)OC)O)O)C |
| TCMBANKIN033678 | caffeine | NCGC00015208-02; DHCplus; KBio2_001781; W222402_ALDRICH; NINDS_000730; EINECS 200-362-1; Spectrum5_000423; BSPBio_001921; KBio1_000730; ACon1_000085; Probes1_000150; Quick-Pep; D00528; AIDS001649; WLN: T56 BN DN FNVNVJ B1 F1 H1; 1,3,7-trimethyl-3,7-dihydro-1H-purine-2,6-dione; SK 65 Compound; NCGC00090699-07; KBio2_006917; Stim; Caffeina [Italian]; 1,3,7-trimethylpurine-2,6-dione; PDSP2_001219; C7731_SIAL; KBioSS_001781; Caffein; Miudol; Nix Nap; nchembio774-comp2; Nodaca; Caffeine (natural); Cafeina; CFF; Caffeine solution; 7-methyltheophylline; 3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion (coffein); Bio1_000962; TNP00310; 75035_FLUKA; 1,3,7-Trimethyl-2,6-dioxopurine; NCGC00090699-08; Caffeine, anhydrous; Koffein [German]; C1778_SIAL; Dexitac; 3,7-dihydro-1,3,7-trimethyl-1H-purine; 3,7-Dihydro-1,3,7-trimethyl-1H-purine-2,6-dione; Durvitan; PDSP2_001000; MLS001066409; Eldiatric C; SPECTRUM1500155; cafeine; Koffein; NCIOpen2_008255; BRN 0017705; 71701-02-5; C8960_SIAL; Bio1_001451; MLS001056714; Caffeine (USP); caffenium; SPBio_001222; 27602_FLUKA; 95789-13-2; Spectrum3_000321; Cafecon; Thein; NCGC00015208-01; Coffeinum; 1-methyltheobromine; Mettler Toledo Calibration substance ME 18872, Caffeine; Kofein [Czech]; NSC 5036; Spectrum_001301; NCGC00090699-04; Bayer Select Headache Pain; Theine; Guaranine; KBio3_001141; NSC5036; 1,3,7-trimethyl-2,6-dioxo-1,2,3,6-tetrahydropurine; Spectrum2_001261; EU-0100228; Probes2_000128; MEGxp0_001350; Anhydrous caffeine (TN); 1,3,7-Trimethylxanthine; 58-08-2; Caffedrine; C07481; No-Doz; PDSP1_001016; 3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion; InChI=1/C8H10N4O2/c1-10-4-9-6-5(10)7(13)12(3)8(14)11(6)2/h4H,1-3H; Phensal; Refresh'n; KBio2_004349; AIDS-001649; Tri-Aqua; Lopac0_000228; ZINC00001084; teina; Methyltheobromine; IDI1_000730; Caffeine, synthetic; 5-26-13-00558 (Beilstein); LS-187843; Theophylline Me; 5-26-13-00558 (Beilstein Handbook Reference); Coffein [German]; C6035_SIGMA; HSDB 36; DivK1c_000730; SDCCGMLS-0064595.P001; KBioGR_002325; NCI-C02733; SBB006474; Spectrum4_001782; Coffeine; Anhydrous caffeine; SMR000326667; 1H-Purine-2,6-dione, 3,7-dihydro-1,3,7-trimethyl-; Theobromine, 1-methyl-; Theophylline, 7-methyl; MolMap_000054; NCGC00090699-01; Theobromine Me; LS-237; Cafamil; Cafipel; c1094; AI3-20154; SDCCGMLS-0064595.P002; Xanthine, 1,3,7-trimethyl; Bio1_000473; Mateina; Methylxanthine theophylline; FEMA No. 2224; CHEBI:27732; Tirend; component of P-A-C Compound; Caffeine; Organex; NCGC00090699-03; component of Cafergot; CCRIS 1314; Methyltheobromide; Lopac-C-0750; 3,7-dihydro-1,3,7-trimethyl-1H-purine (9CI); Alert-Pep; C0750_SIAL; PDSP1_001235; Anhydrous caffeine (JP15); Vivarin; Caffeine [BAN:JAN]; Coffein; Caffine | C8H10N4O2 | 194.19 | CN1C=NC2=C1C(=O)N(C(=O)N2C)C |
| TCMBANKIN033723 | Deoxyandrographolide | 4-[2-[(4aS,5R,6R,8aR)-6-hydroxy-5-(hydroxymethyl)-2,5,8a-trimethyl-3,4,4a,6,7,8-hexahydronaphthalen-1-yl]ethyl]-2H-furan-5-one; BG01310040; AC-20219; DTXSID60616868; 79233-15-1; ANDROGRAPHOLIDE, DEOXY-; deoxyandrographolide; ZINC21992845; 9342AF; MolPort-005-938-522; AKOS015965180; 3-{2-[(4aS,5R,6R,8aR)-6-Hydroxy-5-(hydroxymethyl)-2,5,8a-trimethyl-3,4,4a,5,6,7,8,8a-octahydronaphthalen-1-yl]ethyl}furan-2(5H)-one; 3-{2-[(4AS,5R,6R,8AR)-6-HYDROXY-5-(HYDROXYMETHYL)-2,5,8A-TRIMETHYL-3,4,4A,6,7,8-HEXAHYDRONAPHTHALEN-1-YL]ETHYL}-5H-FURAN-2-ONE; AN-36619; CS-3655; AK546859; HY-N0857; 14-deoxyandrographolide(14-DAP) | C20H30O4 | 334.45 | CC1=C(C2(CCC(C(C2CC1)(C)CO)O)C)CCC3=CCOC3=O |
| TCMBANKIN033787 | denudatine | C22H33NO2 | 343.5 | CCN1CC2(CCCC34C2CC(C31)C56C4C(C(CC5)C(=C)C6O)O)C | |
| TCMBANKIN035468 | Delsemine B | delsemine b | C37H53N3O10 | 699.8 g/mol | CCN1CC2(CCC(C34C2C(C(C31)(C5(CC(C6CC4C5C6OC)OC)O)O)OC)OC)COC(=O)C7=CC=CC=C7NC(=O)CC(C)C(=O)N |
| TCMBANKIN035484 | (2R,3S,5S)-5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol | (2R,3S,5S)-5-(6-amino-9-purinyl)-2-(hydroxymethyl)-3-tetrahydrofuranol; (2R,3S,5S)-5-(6-aminopurin-9-yl)-2-methylol-tetrahydrofuran-3-ol; (2R,3S,5S)-5-(6-aminopurin-9-yl)-2-(hydroxymethyl)tetrahydrofuran-3-ol | C10H13N5O3 | 251.24 | |
| TCMBANKIN035736 | Deltamine | deltamine | C9H8N2O2 | 176.17 | C1=CC=C(C=C1)C2C(=O)N=C(O2)N |
| TCMBANKIN036216 | deltaline | NSC624745; NSC-624745 | C27H41NO8 | 507.6 g/mol | CCN1CC2(CCC(C34C2C(C5(C31)C6(CC(C7CC4(C6C7OC)O)OC)OCO5)OC(=O)C)OC)C |
| TCMBANKIN036312 | 20-Hexadecanoylingenol | 20-hexadecanoylingenol | C36H58O6 | 586.94 | CCCCCCCCCCCCCCCC(=O)OCC1=CC2C3C(C3(C)C)CC(C4(C2=O)C=C(C(C4(C1O)O)O)C)C |
| TCMBANKIN036815 | berberine | berberine ; isoquinoline alkaloid | C20H18NO4 | 337 | C12=N(C([H])([H])C([H])([H])c(c([H])c(OC([H])([H])O3)c3c4[H])c14)C([H])=C(C(OC([H])([H])[H])=C(OC([H])([H])[H])C([H])=C5[H])C5=C2[H] |
| TCMBANKIN036843 | isotalatizidine | 7633-68-3; Isotalatizidine; ZINC70687988 | C23H37NO5 | 407.54 | CCN1CC2(CCC(C34C2CC(C31)C5(CC(C6CC4C5C6O)OC)O)O)COC |
| TCMBANKIN036921 | Fuzinoside | 416.37 g/mol | |||
| TCMBANKIN037440 | Uridine | URI; SBB000838; 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)-2-tetrahydrofuranyl]pyrimidine-2,4-dione; SMR000058222; MLS000069625; AIDS185903; 1-beta-D-Ribofuranosyluracil; NSC 20256; 1-[(2R,5R)-3,4-DIHYDROXY-5-(HYDROXYMETHYL)OXOLAN-2-YL]-3H-PYRIMIDINE-2,4-DIONE; SY005419; AKOS015960347; MolPort-005-932-481; AC-10519; araU; 12693-39-9; ZINC02583633; 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione; AB0012293; Uracil-1-beta-D-ribofuranoside; SCHEMBL890304; NCGC00142368-01; C00299; 1-beta-D-ribofuranosylpyrimidine-2,4(1H,3H)-dione; BG00950366; U3750_SIGMA; Uridine, labeled with tritium; AI3-52690; AIDS-185903; U3003_SIGMA; AS-12665; Uracil, 1-beta-D-ribofuranosyl-; 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-methylol-tetrahydrofuran-2-yl]pyrimidine-2,4-quinone; 21231-59-4; U6381_SIGMA; SMP1_000029; CHEBI:16704; 68184-15-6; 1-((2r,5r)-3,4-dihydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-1h-pyrimidine-2,4-dione; 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidine-2,4-dione; EINECS 200-407-5 | 244.201 | ||
| TCMBANKIN037862 | Ignavine | Hetisan-2,13,9,15-tetrol, 2-benzoate, (2-alpha,3-beta,15-beta)-; Ignavine; AC1MHZ5Y; LS-74800; BRN 5655872 | 449.54 | ||
| TCMBANKIN038126 | Isodelphinine | 599.7 g/mol | |||
| TCMBANKIN038492 | 14-o-anisoylneoline | C32H45NO8 | 571.7 g/mol | CCN1CC2(CCC(C34C2C(C(C31)C5(CC(C6CC4C5C6OC(=O)C7=CC=C(C=C7)OC)OC)O)OC)O)COC | |
| TCMBANKIN038860 | benzoylaconine | benzoylaconine | C32H45NO10 | 603.7 | CCN1CC2(C(CC(C34C2C(C(C31)C5(C6C4CC(C6OC(=O)C7=CC=CC=C7)(C(C5O)OC)O)O)OC)OC)O)COC |
| TCMBANKIN038961 | 5α,8α-epidioxyergosta-6,9(11),22-trien-3α-ol | C28H42O3 | |||
| TCMBANKIN039967 | 14-o-veratroylneoline | 602 | CCN1CC2(CCC(C34C2C(C(C31)C5(CC(C6CC4C5C6OC(=O)C7=CC(=C(C=C7)OC)OC)OC)O)OC)O)COC | ||
| TCMBANKIN040300 | 13-Deoxo-13 alpha-acetyloxy-1-deoxynortaxine I | 13-deoxo-13 alpha-acetyloxy-1-deoxynortaxine i | C33H45NO8 | 583.79 | |
| TCMBANKIN041272 | stearic acid | 4-02-00-01206 (Beilstein Handbook Reference); AIDS-049230; Emersol 871; 8039-52-9; 126539-56-8; stearic acid, ion(1-); D00119; octadecoic acid; Hydrofol Acid 150 (VAN); 134503-33-6; Fatty acids C16-18; 68937-76-8; Kam 2000; VLZ 200; Lunac S 98; Glycon S-80; Hy-phi 1205; Lunac YA; Pristerene 9429; Pristerene 4900; Octadecanoic acid (9CI); Hystrene 9718NF; Edenor FHTI; Cetylacetic acid; NAA 173; NSC 25956; Lunac S 90; S 30C S 30C (fatty acid); Neo-Fat 18-61; Dar-chem 14; NSC25956; Edenor HT-JG 60; Octadecanoate; 57485-56-0; Oktadekansaeure; S 300 (fatty acid); Unister NAA 180; Industrene 5016; Prisorine 3508; Hydrofol Acid 150; Hystrene 4516; G 270; Stearic Acid Cherry; Century 1230; 822-16-2 (SODIUM SALT); NCGC00091596-02; Glycon S-90; 85404-83-7; NCGC00091596-01; Stearic acid (JP15/NF); Hystrene 5016; Hy-phi 1303; Glycon S-70; C01530; Octadecansaeure; Neo-Fat 18-55; WO 2 (fatty acid); Pristerene 9559; SA 200; Century 1240; Stearic acid, pure; Sunfat 18S; WO 2; CHEBI:28842; Industrene 5016K; LS-2392; Kam 3000; BRN 0608585; Edenor ST 20; AIDS049230; Lunac 30; EINECS 273-087-8; Emersol 150; 175366_SIAL; 8039-54-1; Fatty acids, C16-20; stearicacid; Stearic acid ion(1-)salt; Stearic acid (8CI); Stearinsaeure; Emersol 153NF; Hydrofol acid 1855; 57-11-4; Lunac S 30; Hystrene T 70; Prisorine 3501; Haimaric MKH(R); Stearex Beads; Groco 55; Hystrene S-97; Neo-Fat 18-54; W303518_ALDRICH; Hydrofol acid 1655; Nonsoul SN 1 (*Sodium salt*); EINECS 200-313-4; 39390-61-9; Emersol 120; EPA Pesticide Chemical Code 079082; Lunac S 20; Octadecanoic acid, ion(1-); 8013-28-3; AI3-00909; Kortacid 1895; FEMA No. 3035; Hystrene S 97; 82497-27-6; Tegostearic 254; SNA-2000 (*Sodium salt*); 1-Heptadecanecarboxylic acid; AC1MHWEJ; STL280244; 27405_RIEDEL; Steric acid; Industrene 9018; Glycon dp; F 3 (lubricant); Hy-phi 1401; Lunac S 50; Emersol 132; Stearic acid, ion(1-) (8CI); CH3-[CH2]16-COO(-); acide octadecanoique; Groco 55l; 73297_FLUKA; Serfax MT 90; Stearic acid [USAN:JAN]; 8039-51-8; acide stearique; Kam 1000; Acidum stearinicul; InChI=1/C18H36O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h2-17H2,1H3,(H,19,20; 8039-53-0; 17FA; Stearophanic acid; 8037-83-0; Hystrene 7018; FA 1655; Prisorine 3502; Nonsoul SK 1; Hydrofol Acid 1895; Lunac S 40; Stearic acid 50; 8023-06-1; 85679_FLUKA; HSDB 2000; n-Octadecanoate; 400JB9103-88; Glycon tp; Unimac 5680; Loxiol G 20; Stearate; 875D; Octadecanoic acid; Neo-Fat 18-53; octadecanoate (n-C18:0); Radiacid 0427; Emery 871; Vanicol; Vis-Plus; PD 185; EINECS 250-178-0; AKOS022105769; 646-29-7; Edenor ST 1; S 300; Caswell No. 801D; Selosol 920; Tegostearic 272; Isostearic acid EX; A 1760; WLN: QV17; Stearic acid (TN); Pearl stearic; 609343-71-7; Palmitic acid - stearic acid mixture; Emersol 875; Industrene 8718; Hystrene 9718NFFG; NCGC00164255-02; ST023799; LMFA01010018; Groco 54; Edenor C18; Hystrene T-70; Hy-phi 1199; CTK8J8420; n-Octadecanoic acid; Groco 58; Pristerene 4963; Formula 300; AFCO-Chem B 65; CCRIS 2305; Industrene R; Century 1220; S4751_SIGMA; Neo-Fat 18; 58392-66-8; Barolub FTA; Hystrene 9718; CH3-[CH2]16-COOH; STE; 8037-40-9; 30399-84-9; Lunac S 90KC; Hydrofol 1895; Emery 875D; Century 1210; QIQXTHQIDYTFRH-UHFFFAOYSA-M; Neo-Fat 18-59; LS-1388; Groco 59; Humko Industrene R; Hystrene 80; Adeka Fatty Acid SA 910; Stearic acid; Prifac 2918; Emersol 6349; Edenor C 18/98; 3uex; LS-97707; CHEBI:25629; Neo-Fat 18-S; Stearic acid - palmitic acid mixture; Tegostearic 255; C-Lube 10 | C18H36O2 | 284 | C([H])([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C(O[H])= O |
| TCMBANKIN041727 | Benzoylmesaconine | 289.33 | |||
| TCMBANKIN043340 | 6-Deoxy-6α-acetoxyatalantin acetate | ||||
| TCMBANKIN046229 | deltoin | AC1NSUCJ; 2-[2-[(Z)-2-methyl-3-oxobut-1-enoxy]propan-2-yl]-2,3-dihydrofuro[3,2-g]chromen-7-one; deltoin | C19H20O5 | 328.359 | c12c(O[C@]([H])(C(C([H])([H])[H])(OC(\C(=C([H])\C([H])([H])[H])\C([H])([H])[H])=O)C([H])([H])[H])C1([H])[H])c([H])c3c(C([H])=C([H])C(=O)O3)c2[H] |
| TCMBANKIN046272 | 14-Deoxy-11,12-didehydroandrographolide | MLS001143514; CHEMBL1326087; 4-[(E)-2-[(1R,5R,6R,8aR)-6-hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylene-decalin-1-yl]vinyl]-2H-furan-5-one; SMR001215698; 3-[(E)-2-[2-Methylene-5,8aalpha-dimethyl-5alpha-(hydroxymethyl)-6alpha-hydroxydecalin-1alpha-yl]vinyl]furan-2(5H)-one; 14-deoxy-11,12-didehydroandrographolide; SCHEMBL13583643; HMS2270M24 | C20H28O4 | 332.43 | CC12CCC(C(C1CCC(=C)C2C=CC3=CCOC3=O)(C)CO)O |
| TCMBANKIN046392 | hypaphorine | NSC130253; AC1MYRI7; MolPort-001-741-904; HMS2271P06; Hypaphorine, >=95% (LC/MS-ELSD); 3-(1H-indol-3-yl)-2-(trimethylammonio)propanoate; CHEMBL448328; NP-005551; SMR000440569; MCULE-3745207364; MLS000876774; SCHEMBL4736466; NSC-130253; 3-(1H-indol-3-yl)-2-(trimethylazaniumyl)propanoate | C14H18N2O2 | 246.3 g/mol | C[N+](C)(C)C(CC1=CNC2=CC=CC=C21)C(=O)[O-] |
| TCMBANKIN046611 | o-aminophenol | Hydroxylamine, O-phenyl-; 4846-21-3; UOKZUTXLHRTLFH-UHFFFAOYSA-N; AKOS006228082; ZINC391872; X4801; A800458; SCHEMBL81184; CHEMBL1213940; N-phenoxyamine; AJ-21148; AC1MDQOQ; phenoxyamine; Phenyl-O-Hydroxylamine; O-phenylhydroxylamine; SC-51401; AK320413; O-(phenyl)hydroxylamine | C6H7NO | 109.13 g/mol | C1=CC=C(C=C1)ON |
| TCMBANKIN046966 | 14-O-Cinnamoylneoline | 568 | |||
| TCMBANKIN047118 | lipohypaconitine | C47H73NO10 | |||
| TCMBANKIN047645 | aconitine | aconitine ; Aconitine | C34H47NO11 | 646 | C1([H])([H])[C@]([H])(OC([H])([H])[H])[C@]2([C@@]([H])([C@@]([H])([C@]3(OC(C([H])([H])[H])=O)[C@@]([H])([C@@]([H])(OC(=O)c4c([H])c([H])c([H])c([H])c4[H])[C@]([C@]([H])(OC([H])([H])[H])[C@]3([H])O[H])( O[H])C5([H])[H])[C@]25[H])[C@]6([H])OC([H])([H])[H])N(C([H])([H])C([H])([H])[H])C7([H])[H])[C@@]6([H])[C@@]7(C([H])([H])OC([H])([H])[H])[C@]1([H])O[H] |
| TCMBANKIN048200 | hypaconitine | Hypaconitine; aconitine alkaloids | C33H45NO10 | 616 | C1([H])([H])[C@]([H])(OC([H])([H])[H])[C@]2([C@@]([H])([C@@]([H])([C@]3(OC(C([H])([H])[H])=O)[C@@]([H])([C@@]([H])(OC(=O)c4c([H])c([H])c([H])c([H])c4[H])[C@]([C@]([H])(OC([H])([H])[H])[C@]3([H])O[H])( O[H])C5([H])[H])[C@]25[H])[C@]6([H])OC([H])([H])[H])N(C([H])([H])[H])C7([H])[H])[C@@]6([H])[C@@]7(C([H])([H])OC([H])([H])[H])C1([H])[H] |
| TCMBANKIN048842 | Cordycedipeptide A | ||||
| TCMBANKIN049264 | mesaconitine | C33H45NO11 | 632 | C1([H])([H])[C@]([H])(OC([H])([H])[H])[C@]2([C@@]([H])([C@@]([H])([C@]3(OC(C([H])([H])[H])=O)[C@@]([H])([C@@]([H])(OC(=O)c4c([H])c([H])c([H])c([H])c4[H])[C@]([C@]([H])(OC([H])([H])[H])[C@]3([H])O[H])( O[H])C5([H])[H])[C@]25[H])[C@]6([H])OC([H])([H])[H])N(C([H])([H])[H])C7([H])[H])[C@@]6([H])[C@@]7(C([H])([H])OC([H])([H])[H])[C@]1([H])O[H] | |
| TCMBANKIN050395 | lipo-14-o-anisoylbikhaconine | ||||
| TCMBANKIN057935 | D-sedoheptulose | (3S,4R,5R,6R)-1,3,4,5,6,7-hexahydroxyheptan-2-one; CHEBI:16802; D-Altro-2-heptulose; D-altro-hept-2-ulose;l-galactoheptulose;d-mannoheptulose;Sedoheptulose; (3S,4R,5R,6R)-1,3,4,5,6,7-hexahydroxyheptan-2-one; D-Sedoheptulose, >=95% (TLC); ZINC8579422; altro-Heptulose; 40A0W1XJ6X; UNII-40A0W1XJ6X; AC1NUSHL; SCHEMBL119427; CHEBI:16802; D-altro-hept-2-ulose; D-Altro-2-heptulose; 3019-74-7;L-Galactoheptulos; D-Sedoheptulose, >=95% (TLC); ZINC8579422; altro-Heptulose; 40A0W1XJ6X; UNII-40A0W1XJ6X; D-Mannoheptulose; AC1NUSHL; SCHEMBL119427; CHEBI:16802; D-altro-hept-2-ulose; D-Altro-2-heptulose; 3019-74-7 | C7H14O7 | 210.18 g/mol | C(C(C(C(C(C(=O)CO)O)O)O)O)O |
| TCMBANKIN057955 | 3-deoxybidensyneoside b | bidensyneoside a2 | C16H22O7 | C(CC#CC#CC=CCO)COC1C(C(C(C(O1)CO)O)O)O | |
| TCMBANKIN058183 | meta-aminophenol | Nako TEG; 3-Hydroxyaniline; WLN: ZR CQ; CI 76545; CI Oxidation Base 7; Fouramine EG; m-Aminofenol [Czech]; 09130_FLUKA; 1-Amino-3-hydroxybenzene; 3-Aminophenol; Tertral EG; 100242_ALDRICH; NCGC00091247-01; AIDS019901; Furro EG; m-Aminofenol; AI3-14871; AIDS-019901; ZINC00157527; CCRIS 4145; m-Aminophenol; 36684_RIEDEL; m-Hydroxyaminobenzene; EINECS 209-711-2; InChI=1/C6H7NO/c7-5-2-1-3-6(8)4-5/h1-4,8H,7H; Pelagol EG; Fourrine EG; m-Hydroxyaniline; NSC1546; 3-Amino-1-hydroxybenzene; Futramine EG; Phenol, m-amino-; NSC 1546; Phenol, 3-amino-; C.I. 76545; Basf ursol eg; Fourrine 65; STK258727; Renal EG; m-Hydroxyphenylamine; 591-27-5; m-Aminophenol [UN2512] [Poison]; CHEBI:28924; HSDB 2586; PHENOL,3-AMINO; C.I. Oxidation Base 7; Ursol EG; C05058;NSC-1546; CI 76545; TL8003775; 75925-EP2308880A1; DSSTox_CID_4497; CJ-01679; TR-032614; AI3-14871; 3-Aminophenol, 98%; BB_SC-7384; CCRIS 4145; SMR001370906; I01-4370; ACMC-1B14M; RP18926; AK109174; AS00213; SBB059791; CHEMBL269755; m-Aminophenol, United States Pharmacopeia (USP) Reference Standard; MolPort-001-790-594; 3-hydroxy-aniline; Fourrine EG; 3-Aminophenol, puriss., 99%; m-Hydroxyaniline; AC1Q51QS; PubChem18119; ST2410473; AMINOPHENOL-3; Fourrine 65; m-Hydroxyphenylamine; BASF ursol EG; CHEBI:28924; CWLKGDAVCFYWJK-UHFFFAOYSA-N; BIDD:GT0645; ZINC157527; C.I. Oxidation Base 7; Ursol EG; PS-9279; 3-Hydroxyaniline; WLN: ZR CQ; 3-hydroxybenzenamine; Fouramine EG; ANW-33166; AJ-15049; 1-Amino-3-hydroxybenzene; 3-Aminophenol; Tertral EG; NCGC00258260-01; LABOTEST-BB LTBB000485; BP-13467; 75925-EP2281563A1; TRA0033231; 3-Aminophenol, PESTANAL(R), analytical standard; META AMINO PHENOL; AKOS000118984; MLS002415740; 3-Aminophenol, purum, >=98.0% (T); A0383; 3-amino phenol; UNII-L3WTS6QT82; BIDD:ER0564; AN-21535; DSSTox_GSID_24497; 3-Amino-1-hydroxybenzene; Futramine EG; Phenol, m-amino-; NSC 1546; LS-256; F3228-0191; DTXSID3024497; BBL011987; amino-3-hydroxybenzene; 3-Aminophenol, Pharmaceutical Secondary Standard; Certified Reference Material; DSSTox_RID_77427; m-Aminophenol [UN2512] [Poison]; 75925-EP2305808A1; HSDB 2586; PHENOL,3-AMINO; NCGC00091247-02; BG00599912; BDBM50428384; J-511713; CI Oxidation Base 7; m-Aminophenol [UN2512] [Poison]; m-Aminofenol [Czech]; ST45255313; UNII-LST7140D72 component CWLKGDAVCFYWJK-UHFFFAOYSA-N; FT-0615052; CAS-591-27-5; Furro EG; 38171-54-9 (mono-hydrochloride salt); DB-024153; KB-86271; meta-aminophenol; Pelagol EG; m-Amino phenol; AC1L1XMR; m-amino-phenol; NSC1546; Phenol, 3-amino-; ACT07279; STK258727; NE10511; AC1Q7AKB; SCHEMBL35586; C05058; Nako TEG; 3-amino-phenol; L3WTS6QT82; EC 209-711-2; NCGC00091247-01; STR01006; m-Aminofenol; Zoba EG; SC-18440; MFCD00007786; VU0606052-1; m-Hydroxyaminobenzene; EINECS 209-711-2; InChI=1/C6H7NO/c7-5-2-1-3-6(8)4-5/h1-4,8H,7H; M-AMINOPHENOL; ZB006713; KS-00000VZ4; HMS3039L12; 68239-81-6 (sulfate); Z319217206; C.I. 76545; Renal EG; 591-27-5; UN 2512 (Salt/Mix); 5-AMINO-PHENOL; Tox21_200706; 51-81-0 (hydrochloride); MCULE-7576733778 | C6H7NO | 109.13 g/mol | C1=CC(=CC(=C1)O)N |
| TCMBANKIN058259 | p-aminophenol;para-aminophenol | 4-AMINO-PHENOL; Tox21_113477; SBB059792; para aminophenol; Fourrine 84; AS04549; 9225-EP2275420A1; DSSTox_GSID_24499; 4-Aminophenol (Acetaminophen Related Compound K) (Paracetamol Impurity K), Pharmaceutical Secondary Standard; Certified Reference Material; Certinal; AKOS000119829; p-Aminofenol; 4-Aminophenol, >=99% (HPLC); AN-24398; CJ-12175; BDBM26195; ST088538; J-004908; FT-0617593; A0384; Benzofur P; Aminophenol, p-; NSC-1545; BB_SC-6973; AKOS016371265; AK-46590; KB-189354; CCRIS 4146; to_000006; BASF Ursol P Base; DSSTox_CID_4499; Tox21_201030; 4NL; ACMC-209aoj; SCHEMBL3424; Para-aminophenol; 4-amino phenol; p-aminobenzenol; Tertral P Base; CI 76550; Acetaminophen Impurity K; BG00599911; 4-aminophenol; 9225-EP2280008A2; p-Aminophenol [UN2512] [Poison]; bmse000462; Phenol, p-amino-; para-hydroxyaniline; AC1Q523U; 4-aminophenol?; Pelagol CP (Salt/Mix); 1-Amino-4-hydroxybenzene; AB1009438; TRA0083709; para-amino-phenol; Phenol, 4-amino-; NCGC00090816-05; 9225-EP2308872A1; Epitope ID:117708; Pelagol Grey CP (Salt/Mix); Ursol P; UNII-R7P8FRP05V; AM86423; NCGC00090816-02; Pelagol Grey P Base; CAS-123-30-8; SGCUT00256; Tox21_113477_1; HSDB 2640; R7P8FRP05V; AJ-333/25022099; Nako Brown R; p-Aminophenol [UN2512] [Poison]; Zoba Brown P Base; AI3-14872; 9225-EP2316829A1; Kodelon; 63084-98-0 (sulfate [2:1]); ST2405553; TR-003672; Takatol; ANW-18113; Rodinal; F2190-0438; NCGC00090816-01; Tox21_113242; J-514454; BBL011574; NCGC00090816-03; 4-hydroxy-aniline; C.I. 76550; 135807-EP2371803A1; PubChem22199; MFCD00007869; 4-Aminophenol, PESTANAL(R), analytical standard; 4-aminobenzenol; phenol derivative, 9; C.I. Oxidation Base 6A; C.I. Oxidation Base 6; PLIKAWJENQZMHA-UHFFFAOYSA-N; Durafur Brown R (Salt/Mix); paraaminophenol; 51-78-5 (hydrochloride); Pelagol P Base; Energol; 4-hydroxyphenylamine; SC-19013; 4-Aminophenol, >=98%; Furro P (Salt/Mix); Fouramine P; p-amino-phenol; Futramine P (Salt/Mix); Paramidophenol; 4-Aminophenol, technical grade, 95%; UN 2512; AC1Q523T; KB-79942; p-hydroxyaniline; AN-22912; Phenol,4-amino-; NSC1545; 4-hydroxyaniline; RP18925; 123-30-8; p-Aminofenol [Czech]; Z57127517; 4-Aminophenol, 250 mug/mL in acetonitrile, certified reference material, ampule of 1 mL; CHEMBL1142; L-1224; AJ-51764; MLS001066356; Durafur Brown RB; I01-0483; NCGC00258583-01; Fourrine P Base; CS-0006652; LS-676; STK286017; 135807-EP2377843A1; MCULE-3319647085; Para Amino Phenol; I924; KS-000000HN; WLN: ZR DQ; Citol; InChI=1/C6H7NO/c7-5-1-3-6(8)4-2-5/h1-4,8H,7H; NSC 1545; Ursol P Base; MolPort-001-641-054; Furro P Base; ZINC4623758; 4-Amino-1-hydroxybenzene; AC1L195P; Azol; p-Hydroxyphenylamine; Renal AC; UNAL; DTXSID3024499; C02372; KSC354Q5H; 4-Aminophenol, United States Pharmacopeia (USP) Reference Standard; SMR000471841; Peltol P (Salt/Mix); NCGC00090816-04; 52985-09-8; DSSTox_RID_77429; BC227837; Paranol; D07MTM; UNII-LST7140D72 component PLIKAWJENQZMHA-UHFFFAOYSA-N; EINECS 204-616-2; Mesalazine impurity A, European Pharmacopoeia (EP) Reference Standard; EC 204-616-2; CHEBI:17602;4-aminophenol; 4-AMINO-PHENOL; ZINC04623758; 35837_RIEDEL; Durafur Brown RB; Phenol, p-amino-; C.I. 76550; Fourrine P Base; AIDS019902; STK286017; A71328_ALDRICH; 1-Amino-4-hydroxybenzene; CPD-259; Fourrine 84; 4-aminobenzenol; WLN: ZR DQ; c0090; InChI=1/C6H7NO/c7-5-1-3-6(8)4-2-5/h1-4,8H,7H; C.I. Oxidation Base 6; p-aminophenol; Citol; NSC 1545; Ursol P Base; Certinal; Pelagol P Base; Furro P Base; Phenol, 4-amino-; p-Aminofenol; Fouramine P; Ursol P; 4-Amino-1-hydroxybenzene; Pelagol Grey P Base; CI 76550; p-Hydroxyphenylamine; Azol; Benzofur P; SGCUT00256; Aminophenol, p-; Renal AC; HSDB 2640; AJ-333/25022099; C02372; CCRIS 4146; to_000006; p-hydroxyaniline; p-Aminophenol [UN2512] [Poison]; SMR000471841; BASF Ursol P Base; Nako Brown R; NSC1545; 60034_RIEDEL; 4-hydroxyaniline; Zoba Brown P Base; 123-30-8; 4NL; p-Aminofenol [Czech]; AI3-14872; 52985-09-8; AIDS-019902; Paranol; p-aminobenzenol; Tertral P Base; EINECS 204-616-2; Rodinal; CHEBI:17602; MLS001066356; 51-78-5 (HCL); NCGC00090816-01;4-AMINO-PHENOL; Tox21_113477; SBB059792; para aminophenol; Fourrine 84; AS04549; 9225-EP2275420A1; DSSTox_GSID_24499; p-aminophenol; 4-Aminophenol (Acetaminophen Related Compound K) (Paracetamol Impurity K), Pharmaceutical Secondary Standard; Certified Reference Material; Certinal; AKOS000119829; p-Aminofenol; 4-Aminophenol, >=99% (HPLC); AN-24398; CJ-12175; BDBM26195; ST088538; J-004908; FT-0617593; A0384; Benzofur P; Aminophenol, p-; NSC-1545; BB_SC-6973; AKOS016371265; AK-46590; KB-189354; CCRIS 4146; to_000006; BASF Ursol P Base; DSSTox_CID_4499; Tox21_201030; 4NL; ACMC-209aoj; SCHEMBL3424; Para-aminophenol; 4-amino phenol; p-aminobenzenol; Tertral P Base; CI 76550; Acetaminophen Impurity K; BG00599911; 4-aminophenol; 9225-EP2280008A2; p-Aminophenol [UN2512] [Poison]; bmse000462; Phenol, p-amino-; para-hydroxyaniline; AC1Q523U; 4-aminophenol?; Pelagol CP (Salt/Mix); 1-Amino-4-hydroxybenzene; AB1009438; TRA0083709; para-amino-phenol; Phenol, 4-amino-; NCGC00090816-05; 9225-EP2308872A1; Epitope ID:117708; Pelagol Grey CP (Salt/Mix); Ursol P; UNII-R7P8FRP05V; AM86423; NCGC00090816-02; Pelagol Grey P Base; CAS-123-30-8; SGCUT00256; Tox21_113477_1; HSDB 2640; R7P8FRP05V; AJ-333/25022099; Nako Brown R; p-Aminophenol [UN2512] [Poison]; Zoba Brown P Base; AI3-14872; 9225-EP2316829A1; Kodelon; 63084-98-0 (sulfate [2:1]); ST2405553; TR-003672; Takatol; ANW-18113; Rodinal; F2190-0438; NCGC00090816-01; Tox21_113242; J-514454; BBL011574; NCGC00090816-03; 4-hydroxy-aniline; C.I. 76550; 135807-EP2371803A1; PubChem22199; MFCD00007869; 4-Aminophenol, PESTANAL(R), analytical standard; 4-aminobenzenol; phenol derivative, 9; C.I. Oxidation Base 6A; C.I. Oxidation Base 6; PLIKAWJENQZMHA-UHFFFAOYSA-N; Durafur Brown R (Salt/Mix); paraaminophenol; 51-78-5 (hydrochloride); Pelagol P Base; Energol; 4-hydroxyphenylamine; SC-19013; 4-Aminophenol, >=98%; Furro P (Salt/Mix); Fouramine P; p-amino-phenol; Futramine P (Salt/Mix); Paramidophenol; 4-Aminophenol, technical grade, 95%; UN 2512; AC1Q523T; KB-79942; p-hydroxyaniline; AN-22912; Phenol,4-amino-; NSC1545; 4-hydroxyaniline; RP18925; 123-30-8; p-Aminofenol [Czech]; Z57127517; 4-Aminophenol, 250 mug/mL in acetonitrile, certified reference material, ampule of 1 mL; CHEMBL1142; L-1224; AJ-51764; MLS001066356; Durafur Brown RB; I01-0483; NCGC00258583-01; Fourrine P Base; CS-0006652; LS-676; STK286017; 135807-EP2377843A1; MCULE-3319647085; Para Amino Phenol; I924; KS-000000HN; WLN: ZR DQ; Citol; InChI=1/C6H7NO/c7-5-1-3-6(8)4-2-5/h1-4,8H,7H; NSC 1545; Ursol P Base; MolPort-001-641-054; Furro P Base; ZINC4623758; 4-Amino-1-hydroxybenzene; AC1L195P; Azol; p-Hydroxyphenylamine; Renal AC; UNAL; DTXSID3024499; C02372; KSC354Q5H; 4-Aminophenol, United States Pharmacopeia (USP) Reference Standard; SMR000471841; Peltol P (Salt/Mix); NCGC00090816-04; 52985-09-8; DSSTox_RID_77429; BC227837; Paranol; D07MTM; UNII-LST7140D72 component PLIKAWJENQZMHA-UHFFFAOYSA-N; EINECS 204-616-2; Mesalazine impurity A, European Pharmacopoeia (EP) Reference Standard; EC 204-616-2; CHEBI:17602;p-aminophenol;para-aminophenol | C6H7NO | 109.13 g/mol | C1=CC(=CC=C1N)O |
| TCMBANKIN058287 | ortho-aminophenol | AC1Q52A5; SBB040832; 2-Aminophenyl alcohol; MolPort-000-871-989; Zoba 3GA; 82735-EP2298758A1; BASF ursol 3GA; 2-Amino-1-hydroxybenzene; 1-Amino-2-hydroxybenzene; 1-Hydroxy-2-aminobenzene; CCRIS 4144; Phenol, o-amino-; CS-D1201; LABOTEST-BB LTBB000484; ZINC00157526; ANW-40536; NCGC00091188-01; STK286021; CI Oxidation Base 17; NSC1534; BIDD:GT0801; DB01726; 2-amino-phenol; EINECS 202-431-1; 2-Hydroxyaniline; 51-19-4 (hydrochloride); RTR-032625; AI3-09065; Mesalazine impurity C, European Pharmacopoeia (EP) Reference Standard; ST2409589; 2-Aminobenzenol; c0316; I01-4364; WLN: ZR BQ; DF10085; 51204-EP2377843A1; TRA0027746; SMR001372016; 2-Aminophenol (Mesalazine Impurity C - PhEur), Pharmaceutical Secondary Standard; Certified Reference Material; KSC206E4P; UNII-23RH73DZ65; Fouramine OP; AC1L1L62; ST50214414; 95-55-6; ZINC157526; NSC-1534; Tox21_200932; 51204-EP2270006A1; CI 76520; Benzofur GG; KS-00000XEM; DB-024292; DSSTox_GSID_24498; 82735-EP2305664A1; 23RH73DZ65; AZ0001-0117; o-Hydroxyphenylamine; TIMTEC-BB SBB040832; Nako Yellow 3GA; MLS002454422; AC1Q516Y; Questiomycin B; 2-Aminophenol, purum, >=98.0% (HPLC); CJ-01678; AN-24323; 2-HYDROXYLANILINE; AKOS BBS-00004290; HSDB 4246; CTK1A6247; NCGC00258486-01; M-5557; 3-bromo-1-methyl-quinolin-2-one; O-AMINOPHENL; H441; Z57127952; 2-Aminophenol, puriss., 99.5%; 2-Aminophenol; TR-032625; 51204-EP2311824A1; 2AF; 82735-EP2298759A1; RL06017; ACT07280; 8CFFFA6B-6ACF-4377-B782-47586CF00CCB; 2-AMINO-PHENOLE; O-Amino phenol; o-Hydroxyaniline; 2-Amino-1-hydroxybenzene; Nako Yellow ga; InChI=1/C6H7NO/c7-5-3-1-2-4-6(5)8/h1-4,8H,7H; Epitope ID:128160; 82735-EP2292608A1; A0335; HMS3039N03; Paradone Olive Green B; 36683_RIEDEL; STR00335; LS-1981; CHEBI:18112; O-AMINOPHENOL; C.I. Oxidation Base 17; 51204-EP2371803A1; UNII-LST7140D72 component CDAWCLOXVUBKRW-UHFFFAOYSA-N; 2-amino-hydroxybenzene; NCGC00091188-03; AJ-15048; bmse000310; UN2512; F2190-0437; 2-amino phenol; C.I. 76520; NCGC00091188-02; 27598-85-2; o-Hydroxyaniline; DSSTox_CID_4498; EBD1686; 2-aminohydroxybenzene; W-100162; SC-22377; AS00211; MCULE-7578442073; MFCD00007690; ACMC-209rze; DTXSID8024498; Mesalamine Impurity C; EXPT00102; FT-0611259; amino-phenol; 2-Aminophenol, 99%; SCHEMBL24436; o-Aminophenol [UN2512] [Poison]; ORTHO AMINO PHENOL; UN 2512 (Related); 51204-EP2278637A1; DSSTox_RID_77428; AK-86065; EC 202-431-1; 2-Aminophenol, PESTANAL(R), analytical standard; NSC 1534; CAS-95-55-6; CDAWCLOXVUBKRW-UHFFFAOYSA-N; AKOS000119785; Benzene, 1-hydroxy-2-amine-; o-Aminophenol [UN2512] [Poison]; 2-Hydroxyanaline; 82735-EP2295432A1; ZB006712; CHEMBL28319; Pelagol Grey GG; Pelagol 3GA; C01987; KB-20799; AB1002390; Phenol, 2-amino-; BG01496300 | C6H7NO | 109.13 g/mol | C1=CC=C(C(=C1)N)O |
| TCMBANKIN058310 | cinnamaldehyde | trans-Cinnamaldehyde, >=98%, FCC, FG; (E)-3-phenylacrolein; DSSTox_GSID_24834; 3-Phenyl-2-propenal; LS-378; UNII-SR60A3XG0F; (3E)-3-phenylprop-2-enal; Cinnamal; ZINC1532777; CS-0009609; (trans)-cinnamaldehyde; NSC-16935; NCGC00091512-02; NSC 16935; ST50213393; D0PJ3M; Aldehyd skoricovy; MolPort-004-288-292; Abion CA; BRN 1071571; 2-propenal, 3-phenyl-, (2E)-; trans-3-Phenylacrolein; FEMA No. 2286; transcinnamaldehyde; Cinnamaldehyde, trans-; Cinnamic aldehyde; DTXSID6024834; 3-Phenylpropenal; 3-Phenyl-2-propen-1-al; 3-phenylprop-2-enal; Cinnamaldehyde (trans), neat; AIDS-097032; BB_NC-2240; trans-Cinnamic aldehyde; NSC40346; TRANS-CINNAMALDEHYDE (SEE ALSO CINNAMALDEHYDE (104-55-2)); CCRIS 6222; trans-3-Phenyl-2-propenal; 3-Fenylpropenal [Czech]; CCRIS 3189; BBL010378; MLS002454394; SCHEMBL3441; NCGC00091512-05; ST5213393; AIDS097032; CNMA; CAS-14371-10-9; Zimtaldehyde; (2E)-3-phenylprop-2-enal; Cinnamaldehyde, United States Pharmacopeia (USP) Reference Standard; InChI=1/C9H8O/c10-8-4-7-9-5-2-1-3-6-9/h1-8H/b7-4; NCGC00259353-01; 2-Propenal, 3-phenyl-, (E)- (9CI); Cassia aldehyde; 3-Phenylacrylaldehyde; 3-Phenylacrolein; NCGC00257017-01; M181; SR60A3XG0F; W228605_ALDRICH; 14371-10-9; Hefty Dog and Cat Repellent; trans cinnamic aldehyde; (E)-Cinnamic aldehyde; NCI-C56111; NSC16935; BDBM50203065; 2-Propenal, 3-phenyl-; (2E)-3-phenylacrylaldehyde; AK-77787; A801001; trans-Cinnamaldehyde, >=99%; GTPL2423; CINNAMALDEHYDE (TRANS); AS-12078; Benzylideneacetaldehyde; Cinnamaldehyde [NF]; BRN 0605737; DB-003796; AC1LCUDE; 58840-EP2308879A1; trans-3-Phenylacrylaldehyde; 2-propenal,3-phenyl-,(E)-; NSC-40346; TR-001003; Tox21_111144; W228613_ALDRICH; 58840-EP2305682A1; STK397371; (2E)-3-Phenyl-2-propenal; KB-81236; NCGC00091512-06; C00903; cinnamaldehyde ; Cinnamaldehyde, (E)-; trans-Cinnamaldehyde, 99%; Tox21_201804; 2-Propenal, 3-phenyl-, (E)-; AK158901; AI3-00473; (E)-3-Phenyl-2-propenal; 104-55-2; MFCD00007000; 96320_FLUKA; R501736; ST24024694; (E)-3-phenyl-acrylaldehyde; 239968_ALDRICH; AJ-26812; Phenylacrolein; trans-Cinnamaldehyde; Aldehyd skoricovy [Czech]; ST2407775; W-205597; Cinnamylaldehyde; LS-850; EINECS 203-213-9; AC1Q6PPL; RL00215; ZINC01532777; ACN-035400; bmse010257; 4-07-00-00984 (Beilstein Handbook Reference); C9H8O; (E)-3-Phenyl-propenal; trans-Cinnamaldehyde, analytical standard; Cinnamic aldehyde (natural); NCGC00091512-07; trans-Cinnamylaldehyde; Tox21_303271; EC 203-213-9; C80687_ALDRICH; EPA Pesticide Chemical Code 040506; Cinnamyl aldehyde; RTR-001003; SMR000112334; AN-24684; beta-phenylacrolein; cinnamic aldehyde, (E)-isomer; CHEBI:16731; WLN: VH1U1R; I14-109742; (E)-3-phenylacrylaldehyde; RT-001454; I14-7336; 2-07-00-00273 (Beilstein Handbook Reference); Epitope ID:150921; trans-Cinnamaldehyde; trans-3-Phenylacrylaldehyde; NCGC00091512-01; DSSTox_RID_77548; AC1Q6BJW; trans cinnamaldehyde; CHEMBL293492; SBB028652; (E)-3-phenyl-2-propenal(E)-cinnamaldehyde; 3-Fenylpropenal; (E)-phenylvinyl aldehyde; trans-Cinmaldehyde; KJPRLNWUNMBNBZ-QPJJXVBHSA-N; Nat. Cinnamaldehyde; (E)-Cinnamaldehyde; NATURAL CINNAMIC ALDEHYDE; FEMA Number 2286; HMS2268O08; AKOS000119171; Cinnemaldehyde; beta-Phenylcrolein; SC-19143; HSDB 209; B99DD6C7-1C6D-4FE3-A172-54BFDB987683; 3-PHENYL-2-PROPENAL (TRANS); CINNAMALDEHYDE; Cinnamaldehyde, Vetec(TM) reagent grade, 93%; AI3-33275; NCGC00091512-04; e-cinnamaldehyde; Cinnamaldehyde, natural, >=95%, FG; (E)-3-phenylprop-2-enal; Acrolein, 3-phenyl-; AM20060482; BG01497386; 3-Phenyl-2-propenaldehyde; N1482; Cinnamaldehyde, 95% 100g; KB-76097; Caswell No. 221A; CINNAMALDEHYDE (SEE ALSO TRANS-CINNAMALDEHYDE (14371-10-9)); CJ-24256; DSSTox_CID_4834; MolPort-000-871-213; (E)-3-Phenylpropenal; Cinnamaldehyde, Natural; Trans- cinnamic aldehyde;(E)-Cinnamaldehyde;3-phenylpropenal;3-phenyl-2-propenalTrans- cinnamic aldehyde;(E)-Cinnamaldehyde;3-phenylpropenal;3-phenyl-2-propenal | C9H8O | 132.16 | C1=CC=C(C=C1)C=CC=O |
| TCMBANKIN058436 | 2, 4-dihydroxy pyrimidine | NSC3970; C00106; 16908-84-2; U3879_SIGMA; 2,4-Pyrimidinediol; 2-hydroxy-4(3H)-pyrimidinone; 66-22-8; Pirod; 144104-68-7; SQ 7726; Uracil-2-14C; 2,4-Pyrimidinedione; 4433-21-0; D00027; 24897-50-5; U0750_SIGMA; AI3-25470; 766-19-8; U1128_SIGMA; SQ 8493; ST5165192; SQ 6201; 2-hydroxy-4(1H)-pyrimidinone; 2,4-Dioxopyrimidine; 1H-pyrimidine-2,4-dione; Urazil; Pyrod; EINECS 200-621-9; Hybar X; Uracil (JAN/USAN); CHEBI:17568; 6-(3,5-Dimethylbenzyl)-5-ethyl-1-[4-(13-ethyl-17-hydroxy-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-ylethynyl)benzyloxymethyl]uracil; Uracil-5-d; NCIMech_000782; AC-907/30002021; 2,4-Dihydroxypyrimidine; 42910-77-0; NSC 3970; NSC29742; ZINC00895045; STK301734; AIDS009895; Uracil (8CI); URACIL; Uracil [USAN]; 6-[(3,5-dimethylphenyl)methyl]-5-ethyl-1-[[4-[2-(13-ethyl-17-hydroxy-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl)ethynyl]phenyl]methoxymethyl]pyrimidine-2,4-dione; pyrimidine-2,4(1H,3H)-dione; 4433-24-3; 2,4-(1H,3H)-pyrimidinedione (9CI); CCRIS 3077; RU 12709; Ura; 2,4(1H,3H)-Pyrimidinedione; BMS 205603-01; InChI=1/C4H4N2O2/c7-3-1-2-5-4(8)6-3/h1-2H,(H2,5,6,7,8; 2,4(1H,3H)-Pyrimidinedione (9CI); NCI60_003718; 4-hydroxy-2(1H)-pyrimidinone; 2,4(1H,3H)-Pyrimidinedione, labeled with tritium; AIDS-009895 | C4H4N2O2 | 112.09 g/mol | C1=CNC(=O)NC1=O |
| TCMBANKIN058450 | ADO | nchembio.2007.56-comp13; CHEBI:16335; Bio1_000437; 9-beta-D-Ribofuranosyl-9H-purin-6-amine; AIDS-001224; 9beta-D-Ribofuranosyladenine; BSPBio_001796; beta-Adenosine; (2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-methylol-tetrahydrofuran-3,4-diol; beta-D-Ribofuranoside, adenine-9; D00045; 46969-16-8; SDCCGMLS-0003108.P003; 4-Aminopyrazolo[3,4-d]pyrimidine ribonucleoside; (2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol; 6-Amino-9-.beta.-ribofuranosyl-9H-purine; NSC 7652; Bio1_001415; Adenosine (JAN/USP); Spectrum2_001257; Spectrum3_000288; Adenosine, homopolymer; ADN; Caswell No. 010B; Adenocard; C00212; SR 96225; Adenocard (TN); EINECS 200-389-9; KBio3_001296; 9H-Purin-6-amine, 9beta-D-ribofuranosyl-; Polyadenosine; beta-D-Ribofuranose, 1-(6-amino-9H-purin-9-yl)-1-deoxy-; (2R,3R,4S,5R)-2-(6-amino-9-purinyl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol; MLS000069638; AI3-52413; 9-beta-D-Ribofuranosidoadenine; A9251_SIGMA; Adenoscan (TN); Bio1_000926; ZINC02169830; CCRIS 2557; NCGC00023673-05; Ade-Rib; nchembio706-5; 30143-02-3; 6-Amino-9-beta-D-ribofuranosyl-9H-purine; Adenosin [German]; NSC 627048; SMR000058216; 9-beta-D-Ribofuranosyladenine; SPBio_001194; beta-D-Adenosine; Adenosine [USAN:BAN]; Polyriboadenosine; (2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol; AIDS001224; 6-Amino-9beta-D-ribofuranosyl-9H-purine; ST009496; Adenoscan; A4036_SIGMA; SPECTRUM1500107; 46946-45-6;SCHEMBL170902; adenosine ; AKOS015960342; AC-5504; BC200893; Adenosine;adenosine;adeninenucleoside | C10H13N5O4 | 267.24 g/mol | C1=NC(=C2C(=N1)N(C=N2)C3C(C(C(O3)CO)O)O)N |
| TCMBANKIN058453 | inosine | 962ABA7D-F602-497D-AD86-94526094D87E; EINECS 200-390-4; I4125_SIGMA; Panholic-L; Inosina [INN-Spanish]; AIDS-008385; Hypoxanthine ribonucleoside; Hypoxanthosine; CHEBI:17596; KBioGR_002560; 12712-98-0; KBio2_007696; BB_NC-0564; Atorel; 1,9-Dihydro-9-beta-D-ribofuranosyl-6H-purin-6-one; 9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)-2-tetrahydrofuranyl]-3H-purin-6-one; beta-Inosine; Hypoxanthine 9-beta-D-ribofuranoside; Ribonosine; MLS000028518; ST5308705; Inosine (8CI,9CI); 6H-Purin-6-one, 1,9-dihydro-9-beta-D-ribofuranosyl-; Trophicardyl; SMP1_000165; InChI=1/C10H12N4O5/c15-1-4-6(16)7(17)10(19-4)14-3-13-5-8(14)11-2-12-9(5)18/h2-4,6-7,10,15-17H,1H2,(H,11,12,18)/t4-,6-,7-,10-/m1/s; Inotin; 132953-54-9; KBioSS_002569; ZINC05127790; AI3-52241; 9-beta-D-ribofuranosyl-9H-purin-6-ol; Inosine (JAN/INN); Hypoxanthine riboside; Oxiamin; Hypoxanthine D-riboside; Inosinum [INN-Latin]; HXR; INO 495; KBio2_005128; 9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-3H-purin-6-one; KBio3_003038; 28861-88-3; 9-beta-D-Ribofuranosylhypoxanthine; Inosin; Inotin (TN); C00294; beta-D-Ribofuranoside, hypoxanthine-9; (-)-Inosine; ZINC02169852; SMR000058316; KBio2_002560; 9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-methylol-tetrahydrofuran-2-yl]-3H-purin-6-one; cMAP_000084; D00054; Hypoxanthine nucleoside; AIDS008385; 9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-3H-purin-6-one; Pantholic-L; Inosine [INN:JAN]; Selfer; 4181-51-5; NSC 20262; Hypoxanthine, 9-beta-D-ribofuranosyl-; (−)-Inosine; hypoxanthinenucleoside; NOS | C10H12N4O5 | 268.23g/mol | C1=NC2=C(C(=O)N1)N=CN2C3C(C(C(O3)CO)O)O |
| TCMBANKIN058454 | glaunine | guanine (1,7-dihydro-form) | C5H5N5O | C1=NC2=C(N1)C(=O)N=C(N2)N | |
| TCMBANKIN058457 | 6-oxo purine | hypoxanthine;HX;9H-Purin-6-ol disodium salt; 6(1H)-Purinone disodium salt; Purin-6(3H)-one disodium salt; 6-Hydroxypurine disodium salt; 1,7-Dihydro-6H-purin-6-one disodium salt; Hypoxanthine disodium salt;AIDS045522; Spectrum3_001352; NCGC00095622-01; C00262; Spectrum5_000564; Imidazo[5,4-d]pyrimidine, 6-hydroxy-; ST5298920; Sarcine; InChI=1/C5H4N4O/c10-5-3-4(7-1-6-3)8-2-9-5/h1-2H,(H2,6,7,8,9,10; CHEBI:17368; Hypoxanthine-8-14C; KBio2_001897; PDSP1_000299; 39464-17-0; 3,7-dihydropurin-6-one; Hypoxanthine enol; 6-Oxopurine; Purin-6-ol; Purin-6(3H)-one; DivK1c_006557; HPA; Hypoxanthine (VAN) (8CI); 9H-Purin-6-ol; 68-94-0; 3H-Purin-6-ol; SDCCGMLS-0065594.P002; KBioSS_001897; SPECTRUM310023; Sarkine; KBio3_002383; Purine-6-ol; ST5298925; 25991-07-5; Spectrum_001417; 9H-Purin-6-ol (VAN); SBB004203; Purin-6(1H)-one; BSPBio_003163; KBio1_001501; SpecPlus_000461; KBio2_004465; ZINC05177813; 25991-09-7; Spectrum2_001907; 480-99-9; AI3-52242; H9636_SIGMA; 9H-Purin-6(1H)-one; AIDS-045522; KBio2_007033; 39464-15-8; 6-Hydroxy-1H-purine; 1,9-Dihydro-purin-6-one; 6(1H)-Purinone; Sarkin; ZINC00155652; 184856-40-4; NSC14665; SDCCGMLS-0065594.P001; TULIP028890; Spectrum4_001742; AG-670/31547063; H9377_SIGMA; PDSP2_000297; 1,7-Dihydro-6H-purin-6-one; 6535-89-3; Purine analog; HYPOXANTHINE; 6-Hydroxypurine; 25991-08-6; EINECS 200-697-3; KBioGR_002184; NSC 14665; H0394_SIGMA; 6H-Purin-6-one, 1,7-dihydro-; SPBio_001874 | C5H4N4O | 136.11 g/mol | C1=NC2=C(N1)C(=O)NC=N2 |
| TCMBANKIN058638 | higenamine | UNII-6016M93W29; CHEBI:27751; (R)-Norcoclaurine; 6,7-Dihydroxy-(1R)-[(4-hydroxyphenyl)methyl]-1,2,3,4-tetrahydroisoquinoline; 6,7-Isoquinolinediol, 1,2,3,4-tetrahydro-1-((4-hydroxyphenyl)methyl)-, (1R)-; (1R)-1-[(4-hydroxyphenyl)methyl]-1,2,3,4-tetrahydroisoquinoline-6,7-diol; 6016M93W29; SCHEMBL5898913; AX8328517; DTXSID90331552; (+)-HIGENAMINE; UNII-TBV5O16GAP component WZRCQWQRFZITDX-CQSZACIVSA-N; CHEMBL501778; 6,7-Isoquinolinediol, 1,2,3,4-tetrahydro-1-((4-hydroxyphenyl)methyl)-, (R)-; C06347; (R)-(+)-Higenamine; (+)-Demethylcoclaurine; 106032-53-5; BDBM50242856; AC1L9ACA; (1R)-1-(4-hydroxybenzyl)-1,2,3,4-tetrahydroisoquinoline-6,7-diol; AK00743742; (R)-1-(4-Hydroxybenzyl)-1,2,3,4-tetrahydroisoquinoline-6,7-diol; Higenamine, (+)-; ZINC896041; demethylcoclaurine; demetahyl coclaurine | C16H17NO3 | 271.31 g/mol | C1CNC(C2=CC(=C(C=C21)O)O)CC3=CC=C(C=C3)O |
| TCMBANKIN059147 | ergosterin | ergosterol;24-Methylcholesta-5,7,22-trien-3beta-ol; 24alpha-Methyl-22E-dehydrocholestero; (3beta,22E)-Ergosta-5,7,22-trien-3-ol; (7S,9AR,11AR)-1-[(2R,3E,5R)-5,6-DIMETHYLHEPT-3-EN-2-YL]-9A,11A-DIMETHYL-1H,2H,3H,3AH,6H,7H,8H,9H,9BH,10H,11H-CYCLOPENTA[A]PHENANTHREN-7-OL; 45480_FLUKA; (24R)-Ergosta-5,7,22-trien-3b-ol; MEGxm0_000450; Ergosterin; 24R-Methylcholesta-5,7,22E-trien-3b-ol; 57-87-4; Ergosterol; ergosta-5,7,22E-trien-3beta-ol; (3beta)-Ergosta-5,7,22-trien-3-ol; C01694; 5,7,22-Ergostatrien-3beta-ol; AIDS064232; E6510_SIGMA; Provitamin D2; (22E)-Ergosta-5,7,22-trien-3.beta.-ol; A831651; ergosta-5,7,22-trienol; ergosta-5,7,22-trien-3 beta-ol; 24R-Methylcholesta-5,7,22E-trien-3beta-ol; ACon0_000429; ERG; ST073383; (3S,10R,13R)-17-[(E,2R,5R)-5,6-dimethylhept-3-en-2-yl]-10,13-dimethyl-2,3,4,9,11,12,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol; 24-Methylcholesta-5,7,22-trien-3b-ol; ACon1_000637; (3beta,2E)-Ergosta-5,7,22-trien-3-ol; Provitamine D2; AIDS-064232; 24a-Methyl-22E-dehydrocholesterol; ergosta-5,7,22-trien-3-ol; 47130U_SUPELCO; LMST01030093; (22E)-ergosta-5,7,22-trien-3beta-ol; ZINC04084618; (3S,9S,10R,13R,14R,17R)-17-[(E,2R,5R)-5,6-dimethylhept-3-en-2-yl]-10,13-dimethyl-2,3,4,9,11,12,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol; 3beta-Hydroxy-5,7,22-ergostatriene; CHEBI:16933; (3S,9S,10R,13R,14R,17R)-10,13-dimethyl-17-[(E,1R,4R)-1,4,5-trimethylhex-2-enyl]-2,3,4,9,11,12,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol; (22E,24S)-24-methylcholesta-5,7,22-trien-3beta-ol | C28H44O | 396.6 g/mol | CC(C)C(C)C=CC(C)C1CCC2C1(CCC3C2=CC=C4C3(CCC(C4)O)C)C |
| TCMBANKIN059149 | Ergosterol peroxide | 2061-64-5; NSC31324; Ergosterol peroxide; 5.alpha.,8.alpha.-Ergosta-6,22-dien-3.beta.-ol, 5,8-epidioxy-; ERGOSTEROL-5,8-PEROXIDE; Ergosterol 5.alpha.,8.alpha.-epidioxide; Ergosta-6,22-dien-3-ol, 5,8-epidioxy-, (3.beta.,5.alpha.,8.alpha.,22E)-; Ergosterol endoperoxide; (3β,5α,8α,22E,24R)-5,8-Epidioxyergosta-6,22-dien-3-ol; 5,8-epidioxyergosta-6,22-dien-3-ol; Peroxyergosterol; ergosterol peroxide; 2061-64-5; ergosterolperoxide; dimethyl-[(E,1R,4R)-1,4,5-trimethylhex-2-enyl][?]ol; (3.beta.,5.alpha.,8.alpha.,22E)-5,8-Epidioxyergosta-6,22-dien-3-ol | C28H44O3 | 428.6 g/mol | CC(C)C(C)C=CC(C)C1CCC2C1(CCC3C24C=CC5(C3(CCC(C5)O)C)OO4)C |
| TCMBANKIN059249 | CLR | 5-Cholesten-3b-ol; Hydrocerin; 5:6-Cholesten-3beta-ol; 209124-38-9; Lidinite; 5:6-Cholesten-3.beta.-ol; Tegolan (VAN); C1231_SIGMA; 3-beta-Hydroxycholest-5-ene; Delta5-Cholesten-3beta-ol; C3292_SIGMA; (3H)-Cholesterol; 20808_RIEDEL; S5442_SIGMA; Cholest-5-en-3-ol, (3-.beta.)-; Super hartolan; Cholesterol (JP15/NF); AIDS338945; 5:6-Cholesten-3-ol; nchembio782-comp1; 3beta-Hydroxy-5-cholestene; delta(sup 5)-Cholesten-3-beta-ol; Dusoline; CHOLESTEROL; D00040; C00187; Provitamin D; Wool alcohols B. P.; Cholest-5-en-3-ol, (3beta)-; Synthetic cholesterol; Dythol; CMC_13392; HSDB 7106; 3beta-Hydroxycholest-5-ene; Cordulan; 5,6-Cholesten-3.beta.-ol; Cholest-5-en-3.beta.-ol; 57-88-5; Kathro; Dusoran; (3beta)-cholest-5-en-3-ol; WLN: L E5 B666 LUTJ A1 E1 FY1&3Y1&1 OQ; 3.beta.-Hydroxycholest-5-ene; 26740_FLUKA; Cholesterol base H; Cholest-5-en-3-ol (3beta)-, labeled with tritium; NCGC00159351-02; 80356-14-5; Cholest-5-en-3-ol, (3.beta.)-; Cholestrin; 5-Cholesten-3beta-ol; ZINC03875383; 218965-24-3; 26732_FLUKA; Cholesterin; C8667_SIGMA; 22243-67-0; Lidinit; Phospholipon & Cholesterol; CHEBI:16113; SyntheChol NS0 Supplement; NSC 8798; nchembio.77-comp1; AI3-03112; Lanol; Cholestrol; AIDS080405; Cholest-5-en-3-ol (3beta)-; 5-Cholesten-3.beta.-ol; SyntheChol; NSC8798; Cholesterol solution; Cholesterol [USAN:JAN]; Nimco cholesterol base H; C8503_SIGMA; BB_NC-0135; SMP1_000069; C3137_SIGMA; Cholesterine; 47127U_SUPELCO; Cholest-5-en-3-beta-ol; Nimco cholesterol base No. 712; AIDS-338945; Cholesteryl alcohol; C3045_SIGMA; 14606_FLUKA; Soya phospholipon & Cholesterol (2:1 molar ratio); AIDS-080405; LMST01010001; CCRIS 2834; (3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol; Cholest-5-en-3beta-ol; Cholesterol (TN); EINECS 200-353-2; Tegolan;cholesterol;8(14)-dehydrocholesterol; 177962-82-2; SCHEMBL5347436; cholesta-5,8(14)-dien-3beta-ol; DJNCIOAUQVURTQ-RQZUOROGSA-N | C27H46O | 386.65 | CC(C)CCCC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)O)C)C |
| TCMBANKIN059453 | Isoergotamine | C33H35N5O5 | 581.66 | CC1(C(=O)N2C(C(=O)N3CCCC3C2(O1)O)CC4=CC=CC=C4)NC(=O)C5CN(C6CC7=CNC8=CC=CC(=C78)C6=C5)C | |
| TCMBANKIN059947 | vitamin b1 | C63H88CoN14O14P | 1356.4 g/mol | CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2] | |
| TCMBANKIN059948 | Vitamin- G | C17H20N4O6 | 376.36 | CC1=CC2=C(C=C1C)N(C3=NC(=O)NC(=O)C3=N2)CC(C(C(CO)O)O)O | |
| TCMBANKIN060652 | cyclo-(ile-val); 3-isopropyl-6-isobutyl-2,5-dioxopiperazine | C11H20N2O2 | 212.29 g/mol | CCC(C)C1C(=O)NC(C(=O)N1)C(C)C | |
| TCMBANKIN060691 | poriferast-5-en-3beta-ol;22,23-dihydrostigmasterol;gamma-sitosterol;clionasterol;beta-dihydrofucosterol | C29H50O | 414.71 g/mol | CCC(CCC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)O)C)C)C(C)C | |
| TCMBANKIN060873 | arachidonic acid | C20H32O2 | 304.5 g/mol | CCCCCC=CCC=CCC=CCC=CCCCC(=O)O | |
| TCMBANKIN060879 | Linolic acid | C18H32O2 | 280.4 g/mol | CCCCCC=CCC=CCCCCCCCC(=O)O | |
| TCMBANKIN060905 | Ricineic acid | C18H32O2 | 280.45 | CCCCCCC=CC=CCCCCCCCC(=O)O | |
| TCMBANKIN060958 | oleic acid;cis-oleic acid;oleinic acid | C18H34O2 | 282.46 | CCCCCCCCC=CCCCCCCCC(=O)O | |
| TCMBANKIN061069 | cholesteryl palmitate | C43H76O2 | 625.1 g/mol | CCCCCCCCCCCCCCCC(=O)OC1CCC2(C3CCC4(C(C3CC=C2C1)CCC4C(C)CCCC(C)C)C)C | |
| TCMBANKIN061091 | stearic acid | CH3(CH2)16COOH | 284.5 g/mol | CCCCCCCCCCCCCCCCCC(=O)O | |
| TCMBANKIN061095 | TGL | C57H110O6 | 891.5 g/mol | CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCC | |
| TCMBANKIN061102 | LFA | C20H42 | 282.55 g/mol | CCCCCCCCCCCCCCCCCCCC | |
| TCMBANKIN061130 | Tamarixinol | C30H54O2 | 446.75 | CCCCCCCCCCCCCCCCCCCCCCCC1=CC(=CC(=C1)OC)O | |
| TCMBANKIN061233 | crassicauline A | C35H49NO10 | 643.76;659.76 | CCN1CC2(C(CC(C34C2C(C(C31)C5(CC(C6(CC4C5C6OC(=O)C7=CC=C(C=C7)OC)O)OC)OC(=O)C)OC)OC)O)COC | |
| TCMBANKIN061236 | Delphamine | C24H39NO7 | 453.6 g/mol | CCN1CC2(CCC(C34C2C(C(C31)(C5(CC(C6CC4C5C6O)OC)O)O)OC)O)COC | |
| TCMBANKIN061239 | Neojiangyouaconitine | C33H47NO9 | 601.73 | CCN1CC2(CCC(C34C2C(C(C31)C5(C6C4CC(C6OC(=O)C7=CC=CC=C7)(C(C5O)OC)O)OC)OC)OC)COC | |
| TCMBANKIN061240 | neoline | C24H39NO6 | 437.57 | CCN1CC2(CCC(C34C2C(C(C31)C5(CC(C6CC4C5C6O)OC)O)OC)O)COC | |
| TCMBANKIN061242 | delbrunine | C25H39NO7 | 465.6 g/mol | CCN1CC2(CCC(C34C2C(C5(C31)C6(CC(C7CC4C6C7O)OC)OCO5)OC)O)COC | |
| TCMBANKIN061675 | berberime | berberine ; isoquinoline alkaloid; berberine | C20H18NO4+ | 336.4 g/mol | COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC5=C(C=C4CC3)OCO5)OC |
| TCMBANKIN061789 | TMPEA | EINECS 200-190-7; NSC30419; 2-(3,4,5-Trimethoxyphenyl)ethylamine; DEA No. 7381; Benzeneethanamine, 3,4,5-trimethoxy-; Mescalin; 2-(3,4,5-trimethoxyphenyl)ethanamine; NINDS_000984; Mezcline; 3,4,5-Trimethoxy-b-phenethylamine; IDI1_000984; DivK1c_000984; Mezcalin; Benzeneethanamine, 3,4,5-trimethoxy- (9CI); Mescaline; Phenethylamine, 3,4,5-trimethoxy-; Phenethylamine, 3,4,5-trimethoxy- (8CI); 54-04-6; Mezcaline; KBio1_000984; Constituent of "Peyote" cacti; 3,4,5-Trimethoxybenzeneethanamine; NSC 30419; 3,4,5-Trimethoxyphenylethylamine; Ethane, 1-amino-2-(3,4,5-trimethoxyphenyl)-; Oprea1_166025; 4-13-00-02919 (Beilstein Handbook Reference); 3,4,5-Trimethoxyphenethylamine; Mescalin [German]; WLN: Z2R CO1 DO1 EO1; Mescline; BRN 1374088; C06546;mescaline;Meskalin; Mescalin; DEA No. 7381; Mezcline; NSC-30419; 1-amino-2-(3,4,5-trimethoxyphenyl)ethane; Constituent of Peyote cacti; Tmpea; SCHEMBL34190; Phenethylamine, 3,4,5-trimethoxy-; 3,4,5-trimethoxy-phenethylamine; Benzeneethanamine,4,5-trimethoxy-; 3,4,5-Trimethoxybenzeneethanamine; A-7488; Ethane, 1-amino-2-(3,4,5-trimethoxyphenyl)-; 3,4,5-trimethoxy-phenylethylamine; 2-(3,4,5-Trimethoxyphenyl)ethanamine; C06546; Benzeneethanamine,3,4,5-trimethoxy-; RHO99102VC; EINECS 200-190-7; mezcalina; 2-(3,4,5-trimethoxyphenyl)-ethylamine; NSC30419; mescalina; 2-(3,4,5-Trimethoxyphenyl)ethylamine; UNII-RHO99102VC; LS-103730; 2-(3,4,5-Trimethoxyphenyl)ethanamine #; Peyote; Ethane,4,5-trimethoxyphenyl)-; 2-(3,4,5-trimethoxy-phenyl)-ethylamine; NSC 30419; D0L8MR; 3,4,5-trimethoxyphenethyl-amine; Mescline; Y9395; HSDB 7503; AJ-08069; Benzeneethanamine, 3,4,5-trimethoxy-; CHEBI:28346; 3,4,5-Trimethoxy-b-phenethylamine; 1954/4/6; DivK1c_000984; IDI1_000984; Mezcalin; AC1L1HCV; Benzeneethanamine, 3,4,5-trimethoxy- (9CI); Phenethylamine, 3,4,5-trimethoxy- (8CI); Mezcaline; KBio1_000984; ZINC1689; DTXSID80202303; CHEMBL26687; 2-(3,4,5-trimethoxy-phenyl)ethylamine; WLN: Z2R CO1 DO1 EO1; NINDS_000984; Constituent of ""Peyote"" cacti; BDBM50059891; RP04786; AKOS000277426; AK153291; J-505719; RHCSKNNOAZULRK-UHFFFAOYSA-N; 3,4,5-Trimethoxyphenylethylamine; 3,5-Trimethoxyphenethylamine; CTK4J9394; 2-(3,4,5-trimethoxyphenyl)-ethyl-amine; Oprea1_166025; 3,5-Trimethoxyphenylethylamine; MFCD00128240; (3,4,5-trimethoxy)-benzylmethylamine; 3,4,5-Trimethoxyphenethylamine; Mescalin [German]; NCGC00247674-01; BRN 1374088 | C11H17NO3 | 211.26 g/mol | COC1=CC(=CC(=C1OC)OC)CCN |
植物对应的疾病
| 疾病ID | 病名 | 疾病类型 | MeSH | 参考文献 |
|---|
植物对应的靶点
| 靶点ID | 基因名 | 基因别名 | 描述 | 染色体位置 | Map_Location | 基因类型 |
|---|
滇ICP备16009434号-1 |
Dai SX Lab